Credo's revenue surged past 160% in the latest twelve months, but Marvell's $9.5 billion scale and heavier debt load tell a ...

Hotter-than-expected inflation in October means the Fed may raise its target rate by a half percentage point next month.

Michael Saylor just floated up to $30 billion in new financing for Strategy. Here's what that number does and doesn't mean.

AGNC’s book value plunged 17% in one quarter, yet its 17.5%-yielding dividend didn’t budge. Here’s why the payout looks safe ...

Novo Nordisk's obesity-drug dominance faces rising rivals, while Pfizer's cheaper valuation and cash flow tell a different ...

Component shortages are holding back shipments, so near-term revenue depends on securing parts rather than on demand alone.

Synopsys earns nearly $1.3 billion in net income on $7.1 billion in revenue, while SentinelOne is still posting a net loss ...

Arm and ASML sit at opposite ends of the chip supply chain, but a sharp gap in their valuations may tip the scales for ...

Arista's margins are running hot, but IBM's steady software pivot and far lower valuation make the 2027 choice closer than ...

Axsome's revenue has climbed about 54% while Moderna's net losses run deep, but a steep valuation gap may tip the scales for ...

Realty Income's 5.4% yield isn't paid quarterly, which can change everything if you are trying to live off your dividend ...

The government can garnish your Social Security benefits if you owe back taxes, child support, or alimony, or if you received ...